The health insurer, currently trading at $235.39 with a market capitalization of $ ... aligning with Mizuho’s bullish outlook. Humana’s long-term growth strategy centers on margin recovery ...

The outcome of this litigation could have substantial implications for Humana’s future revenue and reimbursement rates. 2. Competitive pressures: The Medicare Advantage market remains highly ...

On June 3, Bernstein SocGen Group analysts reiterated an ‘Outperform’ rating on Humana Inc. (NYSE: HUM) and a $313 price ...

CVS Health, once thought of as the ugly duckling of the healthcare industry, is starting to turn things around. Read why CVS ...

At the insurer's investor day, Humana struck a middle ground in defending the importance of the privatized Medicare program — ...

Molina Healthcare provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare ...

Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside ...

The company has recently faced headwinds related to its star ratings, which play a crucial role in determining reimbursement rates and attracting customers in the competitive Medicare Advantage market ...

But, less than two months later, the company is in a state of free fall. Its collapse reflects not simply the troubles of the broader health care market, but also the troubles with Medicare Advantage, ...

Blue Cross Blue Shield of Michigan is engaged in the most consequential reimbursement negotiations with hospitals in its 86-year history. The Detroit insurer, the state’s most dominant with a 63% ...

Investors long trusted UnitedHealth to deliver earnings beats, despite limited transparency. Now they want answers.

While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ...